Clinical Trial Update: A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety, tolerability, and efficacy of SHR-1209 in patients with familial hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia

Drugs mentioned

• SHR-1209

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Familial Hypercholesterolemia | Phase 2 | Status: UNKNOWN